journal article·2024-09-13

Dual-Targeting Nanoplatform Based on Rolling Circle Amplification for Enhanced Multimodal Synergistic Treatment of Breast Cancer

Xiaobing Huo, Zhiqing Zhang, Huan Du, Ruyan Zhang, Jinfeng Zheng, Ting Zhou, Xiufeng Wang, Guodong Zhang, Fang Wang

ACS Applied Polymer Materials· Volume 6· Issue 17
Publisher page

Abstract

We present a rolling circle amplification (RCA)-based nanoplatform that integrates dual-targeting, photothermal therapy (PTT), chemodynamic therapy (CDT), gene therapy (GT), and chemotherapy (CT) for synergistic breast cancer therapy. First, RCA-assembly (RA) was constructed by integrating RCA and three single-stranded DNA (ssDNA) with different functions (S2.2 aptamer chain, 17-E DNAzyme chain, and carboxyl chain). Then, RA-Dox (RD) was further constructed based on the property of doxorubicin (Dox) autonomously binding to G–C bases. Finally, Fe 3 O 4 NPs modified with citrate and polydopamine nanoshell (CFO@PDA NPs) were loaded onto RD through an amidation reaction, which was named CFO@PDA@RD. In vitro MCF-7 cell experiments demonstrated that dual-targeting significantly enhanced the uptake of nanoplatform by MCF-7 cells. The nanoplatform not only has excellent photothermal performance but can also catalyze H 2 O 2 to generate hydroxyl radicals ( • OH) in situ and consume reduced glutathione (GSH) to diminish the antioxidant capacity of the tumor. Degradation of the nanoplatform resulted in the release of Fe 2+ for the activation of DNAzyme for the cleavage of miRNA-21 overexpressed in MCF-7 cells. In addition, the high loading and effective release of Dox by nanoplatform further endowed the nanoplatform with a chemotherapy effect. In summary, the CFO@PDA@RD nanoplatform with a multimodal synergistic treatment effect has great potential in breast cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China

Funding

Fundamental Research Funds for the Central Universities · Natural Science Foundation of Shandong Province

References (57)

Show source-provided references
1. 10.3390/jpm1108077110.3390/jpm11080771 ↗
2. 10.1021/acsapm.3c0204210.1021/acsapm.3c02042 ↗
3. 10.1016/j.jconrel.2020.09.03510.1016/j.jconrel.2020.09.035 ↗
4. 10.1002/smll.20220662410.1002/smll.202206624 ↗
5. 10.1039/D3TB02797J10.1039/D3TB02797J ↗
6. 10.1038/s41467-021-24961-510.1038/s41467-021-24961-5 ↗
7. 10.1016/j.mtchem.2023.10140010.1016/j.mtchem.2023.101400 ↗
8. 10.3390/ma1205077910.3390/ma12050779 ↗
9. 10.1063/5.004767210.1063/5.0047672 ↗
10. 10.1002/smll.20231215310.1002/smll.202312153 ↗
11. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
12. 10.3390/ijms24151200110.3390/ijms241512001 ↗
13. 10.7150/thno.4256410.7150/thno.42564 ↗
14. 10.1016/j.jconrel.2020.08.03610.1016/j.jconrel.2020.08.036 ↗
15. 10.1002/smll.20200396910.1002/smll.202003969 ↗
16. 10.1021/acs.analchem.9b0159110.1021/acs.analchem.9b01591 ↗
17. 10.1021/acsnano.9b0443610.1021/acsnano.9b04436 ↗
18. 10.1021/acsami.6b1120910.1021/acsami.6b11209 ↗
19. 10.1016/j.cis.2022.10268910.1016/j.cis.2022.102689 ↗
20. 10.1126/science.114724110.1126/science.1147241 ↗
21. 10.1016/j.jmst.2020.05.05510.1016/j.jmst.2020.05.055 ↗
22. 10.1016/j.bioactmat.2020.04.00310.1016/j.bioactmat.2020.04.003 ↗
23. 10.1002/adma.20120468310.1002/adma.201204683 ↗
24. 10.1021/acsami.1c2406610.1021/acsami.1c24066 ↗
25. 10.1021/am501391z10.1021/am501391z ↗
26. 10.1039/C5TB02784E10.1039/C5TB02784E ↗
27. 10.1016/j.actbio.2021.04.01910.1016/j.actbio.2021.04.019 ↗
28. 10.3390/polym1006057010.3390/polym10060570 ↗
29. 10.1002/adfm.20187023410.1002/adfm.201870234 ↗
30. 10.1016/j.actbio.2020.04.04110.1016/j.actbio.2020.04.041 ↗
31. 10.1038/s41573-019-0017-410.1038/s41573-019-0017-4 ↗
32. 10.1158/0008-5472.CAN-18-247410.1158/0008-5472.CAN-18-2474 ↗
33. 10.1016/j.ccr.2022.21465110.1016/j.ccr.2022.214651 ↗
34. 10.1038/s41573-021-00162-z10.1038/s41573-021-00162-z ↗
35. 10.1021/acs.nanolett.9b0178510.1021/acs.nanolett.9b01785 ↗
36. 10.1021/acsnano.9b0485710.1021/acsnano.9b04857 ↗
37. 10.1021/acsnano.7b0921010.1021/acsnano.7b09210 ↗
38. 10.1002/adfm.20160170310.1002/adfm.201601703 ↗
39. 10.1038/nbt.161810.1038/nbt.1618 ↗
40. 10.3390/cancers1404087210.3390/cancers14040872 ↗
41. 10.1002/smtd.20170031910.1002/smtd.201700319 ↗
42. 10.1038/am.2017.3410.1038/am.2017.34 ↗
43. 10.1021/acs.chemrev.0c0133210.1021/acs.chemrev.0c01332 ↗
44. 10.1039/c3cs60439j10.1039/c3cs60439j ↗
45. 10.1016/j.trac.2019.11570010.1016/j.trac.2019.115700 ↗
46. 10.1016/j.jcis.2021.11.03110.1016/j.jcis.2021.11.031 ↗
47. 10.1021/acsami.2c1039710.1021/acsami.2c10397 ↗
48. 10.1016/j.bios.2016.07.09510.1016/j.bios.2016.07.095 ↗
49. 10.1021/acsabm.9b0062210.1021/acsabm.9b00622 ↗
50. 10.1021/acs.analchem.0c0189510.1021/acs.analchem.0c01895 ↗
51. 10.1021/acs.nanolett.1c0172710.1021/acs.nanolett.1c01727 ↗
52. 10.1021/acsnano.1c0900810.1021/acsnano.1c09008 ↗
53. 10.1021/acsbiomaterials.0c0028810.1021/acsbiomaterials.0c00288 ↗
54. 10.1021/acs.biomac.2c0127110.1021/acs.biomac.2c01271 ↗
55. 10.1016/j.actbio.2019.02.03210.1016/j.actbio.2019.02.032 ↗
56. 10.1002/anie.20200365310.1002/anie.202003653 ↗
57. 10.1002/adfm.20200275310.1002/adfm.202002753 ↗